NCT05912374

Brief Summary

The goal of this pilot work was to determine if the cognitive dysfunction accommodation strategies help patients retain/utilize more HIV prevention information and increase PrEP adherence. Fifty people who inject drugs (PWID) were prescribed PrEP and randomized to one of two conditions, Twenty-five PWID participated in a standard HIV prevention session and 25 other PWID participated in a HIV prevention session with the included accommodation strategies. At recruitment participants were asked to provide self-report of the screening form and cognitive functioning. The intervention consisted of a total of 5 sessions: 1 meeting to gain baseline information of participants and 4 intervention sessions. Participants completed the consent form, demographics, skills assessment, drug use behavior assessment, and HIV risk behavior assessment at the pre-interview meeting. Participants completed PrEP uptake assessments and skills assessments immediately following the intervention to compare the pre/post results between the two groups. All participants also completed an acceptability rating to help researchers determine the acceptability of the accommodation strategies used, at the end of the 4th session. The objective was to determine if the proposed accommodation strategies are feasible and efficacious at improving HIV prevention outcomes, including knowledge and skills. Information gleaned from this process will be used to refine the intervention approach for future testing and implementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 7, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

June 1, 2023

Last Update Submit

June 12, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • HIV risk reduction skills assessment at baseline

    a 15 item checklist of HIV risk reduction skills, the lower the score the lower the ability to perform HIV risk reduction skills

    pre intervention (week 0)

  • HIV risk reduction skills assessment, post intervention

    a 15 item checklist of HIV risk reduction skills, the lower the score the lower the ability to perform HIV risk reduction skills

    post intervention (week 4)

  • number of participants who picked up PrEP prescription

    PrEP prescription filled by pharmacy

    post intervention (week 4)

Secondary Outcomes (3)

  • number of participants recruited

    pre intervention (week 0)

  • number of participants retained throughout study

    post intervention (week 4)

  • Intervention Acceptability

    post intervention (week 4)

Study Arms (2)

Control arm with standard intervention

ACTIVE COMPARATOR

Participants will complete a 4-week CHRP-BB standard intervention

Behavioral: standard Community-Friendly Health Recovery Program- Biobehavioral (CHRP-BB)

Experimental arm with enhanced intervention

EXPERIMENTAL

Participants will complete a 4-week CHRP-BB intervention enhanced with included cognitive dysfunction accommodation strategies.

Behavioral: enhanced Community-Friendly Health Recovery Program- Biobehavioral (CHRP-BB)

Interventions

CHRP-BB is an evidence-informed behavioral intervention for HIV prevention among high-risk drug users in treatment on PrEP. CHRP-BB consists of 4 weekly 50- minute sessions.

Control arm with standard intervention

The enhanced version of CHRP-BB is an adapted behavioral intervention for HIV prevention among high-risk drug users in treatment on PrEP. This intervention consists of 4 weekly 50- minute sessions that include cognitive dysfunction accommodation strategies.

Experimental arm with enhanced intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • at least 18 years or older
  • reported injection drug use in the past 30 days
  • reported engagement in drug- and/or sex- related HIV risk behaviors
  • HIV negative
  • are willing to initiate PrEP use
  • can communicate (read, write and speak) in English
  • experience mild/moderate level of cognitive dysfunction

You may not qualify if:

  • cannot attend all study sessions
  • actively homicidal and/or suicidal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

APT Foundation

New Haven, Connecticut, 06519, United States

Location

Related Publications (1)

  • Mistler CB, Shrestha R, Copenhaver MM. Testing the feasibility, acceptability, and preliminary efficacy of integrating accommodation strategies into an HIV prevention intervention for people who inject drugs with cognitive dysfunction. J Subst Use Addict Treat. 2025 Feb;169:209582. doi: 10.1016/j.josat.2024.209582. Epub 2024 Nov 17.

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Michael B Copenhaver, PhD

    University of Connecticut

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
single blind
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: randomized controlled pilot trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 1, 2023

First Posted

June 22, 2023

Study Start

September 7, 2022

Primary Completion

December 12, 2022

Study Completion

December 12, 2022

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations